Clinical Trial

Once Weekly Infant Corticosteroid Trial for DMD

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The hypothesis tested here is that a lower dose of intermittent oral corticosteroids (5mg/kg/week) will be equally effective to the 10mg/kg/week dose.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-08 -> 2028-08 2026-08-15
minor Completion pushed: 2026-12 -> 2028-12 2026-08-15
Trial Details
NCT Number NCT05412394
Lead Sponsor Anne M. Connolly
Collaborators: Children's Hospital Medical Center, Cincinnati, Muscular Dystrophy Association, University of Texas, Virginia Commonwealth University, Ann & Robert H Lurie Children's Hospital of Chicago
Conditions Duchenne Muscular Dystrophy
Enrollment 26 participants
Start Date 2021-04-30
Primary Completion 2028-08 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-14